Bruce Cutler to Humans
This is a "connection" page, showing publications Bruce Cutler has written about Humans.
Connection Strength
0.038
-
Wong G, Li JM, Hendricks G, Eslami MH, Rohrer MJ, Cutler BS. Inhibition of experimental neointimal hyperplasia by recombinant human thrombomodulin coated ePTFE stent grafts. J Vasc Surg. 2008 Mar; 47(3):608-15.
Score: 0.012
-
McPhee JT, Asham EH, Rohrer MJ, Singh MJ, Wong G, Vorhies RW, Nelson PR, Cutler BS. The midterm results of stent graft treatment of thoracic aortic injuries. J Surg Res. 2007 Apr; 138(2):181-8.
Score: 0.011
-
Li JM, Singh MJ, Nelson PR, Hendricks GM, Itani M, Rohrer MJ, Cutler BS. Immobilization of human thrombomodulin to expanded polytetrafluoroethylene. J Surg Res. 2002 Jun 15; 105(2):200-8.
Score: 0.008
-
Robinson WP, Schanzer A, Cutler BS, Baril DT, Larkin AC, Eslami MH, Arous EJ, Messina LM. A randomized comparison of a 3-week and 6-week vascular surgery simulation course on junior surgical residents' performance of an end-to-side anastomosis. J Vasc Surg. 2012 Dec; 56(6):1771-80; discussion 1780-1.
Score: 0.004
-
Li JM, Singh MJ, Itani M, Vasiliu C, Hendricks G, Baker SP, Hale JE, Rohrer MJ, Cutler BS, Nelson PR. Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 2004 May; 39(5):1074-83.
Score: 0.002
-
Cote MC, Ligeti R, Cutler BS, Nelson PR. Management of hyperlipidemia in patients with vascular disease. J Vasc Nurs. 2003 Jun; 21(2):63-7; quiz 68-9.
Score: 0.002